Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2003-10-02
2010-02-23
Goldberg, Jeanine A (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S023100, C536S024300
Reexamination Certificate
active
07666589
ABSTRACT:
The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods of identifying methylation patterns in genes associated with specific cancers.
REFERENCES:
patent: 6605432 (2003-08-01), Huang
Yan et al. (Clinical Cancer Research, vol. 6, pp. 1432-1438, Apr. 2000).
Ferguson et al. (Current Genomics, vol. 1, pp. 41-58, 2000).
Herman et al. (Cancer Research, vol. 56, pp. 722-727, Feb. 1996).
Bovenzi et al (Anti-Cancer Drugs, vol. 10, pp. 471-476, 1999).
Du et al. (Cancer Research, vol. 61, pp. 8094-8099, Nov. 2001).
Paz et al (Cancer Research, vol. 62, pp. 4519-4524, Aug. 2002).
Worm et al. (J. of Biological Chemistry, vol. 276, No. 43, pp. 39990-40000, Aug. 2001).
Kusui et al. “DNA Methylation of the human oxytocin receptor gene promoter regulates tissue-specific gene suppression” Biochemical and Biophysical Research Communications. vol. 289, pp. 681-686, 2001.
Maat et al. (Investigative Ophthalmology, Visual Science, vol. 48, No. 2, pp. 486-490, Feb. 2007).
Henrique et al. (Clin Cancer Research, vol. 13, No. 20, pp. 6122-6129, Oct. 2007).
Suzuki et al. (Cancer Letters, vol. 242, pp. 222-230, 2006).
Chang et al. (J. Mol. Med, vol. 83, pp. 132-139, 2005).
Maruya et al. (Clinical Cancer Research, vol. 10, pp. 3825-3830, Jun. 2004).
House (J. Gastrointest Surg, vol. 7, pp. 1004-1014, 2003).
Wong (Cancer Research, vol. 39, pp. 71-73, 1999).
Broude et al. (PNAS, vol. 98, No. 1, pp. 206-211, Jan. 2001).
Pogribny et al. (Biochemical and Biophysical Research Communications, vol. 262, pp. 624-628, 1999).
Yang et al (Gynecologic Oncology, vol. 93, pp. 435-440, 2004).
Miyamoto et al. (Jpn, J. Clin, Oncol, vol. 35, No. 6, pp. 293-301, 2005).
Cooper et al., DNA 2:131 [1983].
Baylin et al., AIDS Res Hum Retroviruses 8:811 [1992].
Rountree et al., Oncogene. 20: 3156 [2001.
Jones, Cancer Res. 46:461 [1986].
Villar-Garea and Esteller, Current Drug Metabolism, 4:11 [2003].
Lin et al. Cancer Research 61:8611 [2001].
Young and Smith J. Biol. Chem. 276:19610 [2001]).
Herman et al., PNAS 93:9821 [1996].
Yang et al., Cancer Res. 61:7025 [2001].
Taylor et al., Leukemia 2001, 15:583-589.
Issa et al., Cancer Res. 57:1678 [1997].
Yang et al., Endocr Relat Cancer. 8: 115-127 [2001]).
Singer-Sam et al., “A quantitative Hpall-PCR assay to measure methylation of DNA from a small number of cells,” Nucleic Acids Res. Feb. 11, 1990;18(3):687.
Singer-Sam et al., “Use of a Hpall-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation,” Mol Cell Biol. Sep. 1990;10(9):4987-9.
Silva, JM et al; Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients; British Journal of Cancer, 1999, vol. 80, No. 8, pp. 1262-1264.
Silva, Jose M. et al; Presence of Tumor DNA in Plasma of Breast Cancer Patients: Clinicopathological Correlations; Cancer Research, Jul. 1, 1999, vol. 59, pp. 3251-3256.
Silva, Jose M. et al; Persistance of Tumor DNA in Plasma of Breast Cancer patients After Mastectomy; Annals of Surgical Oncology, 2002, vol. 9, No. 1, pp. 71-76.
UniProtKB/Swiss-Prot entry P53355; Available as of Oct. 31, 2008.
UniProtKB/TrEMBL entry Q9UET8; Available as of Oct. 31, 2008.
UniProtKB/Swiss-Prot entry Q9ULC4; Available as of Oct. 31, 2008.
UniProtKB/Swiss-Prot entry P42771; Available as of Oct. 31, 2008.
UniProtKB/Swiss-Prot entry Q02548; Available as of Oct. 31, 2008.
UniProtKB/Swiss-Prot entry P07996; Available as of Oct. 31, 2008.
UniProtKB/Swiss-Prot entry O14788; Available as of Oct. 31, 2008.
UniProtKB/Swiss-Prot entry P40337; Available as of Oct. 31, 2008.
Sharma, Gayatri et al, “Promoter Hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in Serum and Tumor DNA from Breast Cancer Patients”, Science Direct, Life Sciences 80 (2007) 1873-1881.
Tan, Sing-Huang et al, “Detection of Promoter Hypermethylation in Serum Samples of Cancer Patients by Methylation-Specific Polymerase Chain Reaction for Tumour Suppressor Genes Including RUNX3”, Oncology Reports 18: 1225-1230, 2007.
Gartenhaus Ronald B.
Levenson Victor V.
Andrus Sceales Starke & Sawall LLP
Goldberg Jeanine A
Northwestern University
LandOfFree
Methylation profile of breast cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methylation profile of breast cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methylation profile of breast cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4158838